ANNX
Annexon, Inc.
+0.15 (+3.69%)4.08USD780K成交股數–市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-09下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 3.4M · 0 |
| 近 180 天 淨額 | 3.4M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-11 | 06-15 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | M 選擇權執行 | 30.6K | 1.85 | 57K | 185K | SEC |
| 2026-05-28 | 05-29 | Satter Muneer A | Director | P 公開市場買進 | 613K | 5.41 | 3.3M | 10.3M | SEC |
| 2026-05-11 | 05-13 | Carson William H. | Director | P 公開市場買進 | 8.0K | 5.78 | 46K | 78.4K | SEC |
| 2026-04-10 | 04-14 | Carson William H. | Director | P 公開市場買進 | 8.0K | 6.20 | 50K | 70.4K | SEC |
| 2026-03-10 | 03-12 | Carson William H. | Director | P 公開市場買進 | 8.0K | 5.67 | 45K | 62.4K | SEC |
| 2026-03-02 | 03-04 | ARTIS DEAN RICHARD | EVP & CHIEF SCIENTIFIC OFFICER | S 公開市場賣出 | 5.9K | 5.43 | 32K | 180K | SEC |
| 2026-03-02 | 03-04 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | S 公開市場賣出 | 4.3K | 5.42 | 24K | 183K | SEC |
| 2026-03-02 | 03-04 | Dananberg Jamie | CHIEF MEDICAL OFFICER | S 公開市場賣出 | 5.8K | 5.43 | 32K | 124K | SEC |
| 2026-03-02 | 03-04 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | S 公開市場賣出 | 5.6K | 5.42 | 30K | 171K | SEC |
| 2026-03-02 | 03-04 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | S 公開市場賣出 | 5.6K | 5.42 | 30K | 154K | SEC |
| 2026-02-19 | 02-23 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | A 獲配股票 | 62.5K | – | – | 160K | SEC |
| 2026-02-19 | 02-23 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | A 獲配股票 | 62.5K | – | – | 187K | SEC |
| 2026-02-19 | 02-23 | Dananberg Jamie | CHIEF MEDICAL OFFICER | A 獲配股票 | 56.3K | – | – | 129K | SEC |
| 2026-02-19 | 02-23 | ARTIS DEAN RICHARD | EVP & CHIEF SCIENTIFIC OFFICER | A 獲配股票 | 62.5K | – | – | 186K | SEC |
| 2026-02-19 | 02-23 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | A 獲配股票 | 62.5K | – | – | 176K | SEC |
| 2026-02-18 | 02-20 | Dananberg Jamie | CHIEF MEDICAL OFFICER | S 公開市場賣出 | 5.3K | 5.10 | 27K | 73.2K | SEC |
| 2026-02-18 | 02-20 | ARTIS DEAN RICHARD | EVP & CHIEF SCIENTIFIC OFFICER | S 公開市場賣出 | 5.3K | 5.10 | 27K | 123K | SEC |
| 2026-02-18 | 02-20 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | S 公開市場賣出 | 7.9K | 5.11 | 40K | 114K | SEC |
| 2026-02-18 | 02-20 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | S 公開市場賣出 | 6.2K | 5.10 | 32K | 124K | SEC |
| 2026-02-18 | 02-20 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | S 公開市場賣出 | 7.9K | 5.11 | 40K | 97.2K | SEC |
| 2025-12-30 | 01-02 | Carson William H. | Director | P 公開市場買進 | 4.1K | 5.02 | 21K | 54.4K | SEC |
| 2025-12-01 | 12-03 | Choi Jung | Director | P 公開市場買進 | 33.0K | 4.19 | 138K | 33.0K | SEC |
| 2025-12-01 | 12-03 | Carson William H. | Director | P 公開市場買進 | 4.1K | 4.47 | 18K | 50.3K | SEC |
| 2025-11-21 | 11-21 | Satter Muneer A | Director | P 公開市場買進 | 423K | 4.28 | 1.8M | 9.7M | SEC |
| 2025-11-20 | 11-21 | Satter Muneer A | Director | P 公開市場買進 | 400K | 4.48 | 1.8M | 9.3M | SEC |
| 2025-11-19 | 11-19 | Satter Muneer A | Director | P 公開市場買進 | 500K | 3.94 | 2.0M | 8.9M | SEC |
| 2025-11-18 | 11-19 | Satter Muneer A | Director | P 公開市場買進 | 500K | 3.18 | 1.6M | 8.4M | SEC |
| 2025-11-17 | 11-19 | Satter Muneer A | Director | P 公開市場買進 | 500K | 2.99 | 1.5M | 7.9M | SEC |
| 2025-10-30 | 10-31 | Carson William H. | Director | P 公開市場買進 | 4.1K | 3.17 | 13K | 46.2K | SEC |
| 2025-09-30 | 10-02 | Carson William H. | Director | P 公開市場買進 | 4.1K | 3.05 | 13K | 42.1K | SEC |
| 2025-09-02 | 09-04 | Carson William H. | Director | P 公開市場買進 | 4.1K | 2.09 | 9K | 37.9K | SEC |
| 2025-07-30 | 08-01 | Carson William H. | Director | P 公開市場買進 | 4.1K | 2.43 | 10K | 33.8K | SEC |
| 2025-07-14 | 07-16 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | S 公開市場賣出 | 1.1K | 2.58 | 3K | 122K | SEC |
| 2025-07-14 | 07-16 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | S 公開市場賣出 | 1.1K | 2.58 | 3K | 105K | SEC |
| 2025-07-14 | 07-16 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | S 公開市場賣出 | 853 | 2.61 | 2K | 131K | SEC |
| 2025-06-30 | 07-01 | Carson William H. | Director | P 公開市場買進 | 4.1K | 2.46 | 10K | 29.7K | SEC |
| 2025-02-18 | 02-20 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | S 公開市場賣出 | 8.3K | 2.91 | 24K | 61.2K | SEC |
| 2025-02-18 | 02-20 | ARTIS DEAN RICHARD | EVP & CHIEF SCIENTIFIC OFFICER | S 公開市場賣出 | 5.5K | 2.97 | 16K | 83.8K | SEC |
| 2025-02-18 | 02-20 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | S 公開市場賣出 | 6.6K | 2.95 | 20K | 86.6K | SEC |
| 2025-02-18 | 02-20 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | S 公開市場賣出 | 6.9K | 2.92 | 20K | 77.8K | SEC |
| 2025-02-18 | 02-20 | Dananberg Jamie | CHIEF MEDICAL OFFICER | S 公開市場賣出 | 5.5K | 2.96 | 16K | 33.5K | SEC |
| 2025-02-13 | 02-18 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | S 公開市場賣出 | 1.8K | 2.99 | 5K | 69.6K | SEC |
| 2025-02-13 | 02-18 | Love Douglas | PRESIDENT AND CEO | S 公開市場賣出 | 5.0K | 2.95 | 15K | 352K | SEC |
| 2025-02-13 | 02-18 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | S 公開市場賣出 | 1.8K | 2.98 | 5K | 84.7K | SEC |
| 2025-02-13 | 02-18 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | S 公開市場賣出 | 1.4K | 2.99 | 4K | 93.2K | SEC |
| 2025-01-06 | 01-08 | Love Douglas | PRESIDENT AND CEO | M 選擇權執行 | 38.0K | 1.41 | 54K | 357K | SEC |
| 2024-12-02 | 12-04 | Carson William H. | Director | P 公開市場買進 | 3.2K | 5.33 | 17K | 25.6K | SEC |
| 2024-10-30 | 11-01 | Love Douglas | PRESIDENT AND CEO | M 選擇權執行 | 36.0K | 1.85 | 67K | 311K | SEC |
| 2024-10-30 | 11-01 | Love Douglas | PRESIDENT AND CEO | M 選擇權執行 | 78.4K | 1.85 | 145K | 275K | SEC |
| 2024-10-15 | 10-17 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | S 公開市場賣出(10b5-1) | 5.4K | 7.41 | 40K | 71.4K | SEC |
| 2024-10-15 | 10-17 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | M 選擇權執行 | 5.4K | 1.85 | 10K | 76.8K | SEC |
| 2024-10-01 | 10-02 | Carson William H. | Director | P 公開市場買進 | 3.2K | 5.97 | 19K | 22.4K | SEC |
| 2024-09-19 | 09-20 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | S 公開市場賣出(10b5-1) | 4.5K | 7.10 | 32K | 0 | SEC |
| 2024-09-12 | 09-16 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | S 公開市場賣出(10b5-1) | 5.5K | 6.16 | 34K | 4.5K | SEC |
| 2024-09-05 | 09-06 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | S 公開市場賣出(10b5-1) | 5.5K | 5.64 | 31K | 10.0K | SEC |
| 2024-09-03 | 09-04 | Carson William H. | Director | P 公開市場買進 | 3.2K | 5.48 | 18K | 19.2K | SEC |
| 2024-08-29 | 08-30 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | S 公開市場賣出(10b5-1) | 5.5K | 5.95 | 33K | 15.5K | SEC |
| 2024-08-01 | 08-05 | Carson William H. | Director | P 公開市場買進 | 3.2K | 6.24 | 20K | 16.0K | SEC |
| 2024-07-15 | 07-17 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | S 公開市場賣出 | 784 | 6.02 | 5K | 94.6K | SEC |
| 2024-07-15 | 07-17 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | S 公開市場賣出 | 1.1K | 6.03 | 7K | 86.5K | SEC |
| 2024-07-15 | 07-17 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | S 公開市場賣出 | 1.1K | 6.02 | 7K | 71.4K | SEC |
| 2024-07-01 | 07-02 | Carson William H. | Director | P 公開市場買進 | 3.2K | 5.00 | 16K | 12.8K | SEC |
| 2024-06-03 | 06-05 | Carson William H. | Director | P 公開市場買進 | 3.2K | 4.83 | 15K | 9.6K | SEC |
| 2024-05-01 | 05-03 | Carson William H. | Director | P 公開市場買進 | 3.2K | 4.68 | 15K | 6.4K | SEC |
| 2024-04-08 | 04-10 | Carson William H. | Director | P 公開市場買進 | 3.2K | 6.07 | 19K | 3.2K | SEC |
| 2024-02-27 | 03-03 | ARTIS DEAN RICHARD | EVP & CHIEF SCIENTIFIC OFFICER | A 獲配股票 | 45.0K | – | – | 129K | SEC |
| 2024-02-27 | 03-03 | Dananberg Jamie | CHIEF MEDICAL OFFICER | A 獲配股票 | 45.0K | – | – | 78.4K | SEC |
| 2024-02-27 | 03-03 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | A 獲配股票 | 45.0K | – | – | 106K | SEC |
| 2024-02-27 | 03-03 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | A 獲配股票 | 45.0K | – | – | 132K | SEC |
| 2024-02-27 | 03-03 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | A 獲配股票 | 45.0K | – | – | 123K | SEC |
| 2024-02-20 | 02-21 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | S 公開市場賣出 | 2.6K | 5.53 | 14K | 82.1K | SEC |
| 2024-02-20 | 02-21 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | S 公開市場賣出 | 2.6K | 5.51 | 14K | 72.5K | SEC |
| 2024-02-20 | 02-21 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | S 公開市場賣出 | 2.0K | 5.48 | 11K | 85.6K | SEC |
| 2024-02-16 | 02-21 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | A 獲配股票 | 39.0K | – | – | 84.7K | SEC |
| 2024-02-16 | 02-21 | Dananberg Jamie | CHIEF MEDICAL OFFICER | A 獲配股票 | 39.0K | – | – | 39.0K | SEC |
| 2024-02-16 | 02-21 | ARTIS DEAN RICHARD | EVP & CHIEF SCIENTIFIC OFFICER | A 獲配股票 | 39.0K | – | – | 89.3K | SEC |
| 2024-02-16 | 02-21 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | A 獲配股票 | 39.0K | – | – | 75.1K | SEC |
| 2024-02-16 | 02-21 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | A 獲配股票 | 39.0K | – | – | 87.6K | SEC |
| 2024-02-12 | 02-14 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | S 公開市場賣出 | 1.8K | 5.54 | 10K | 45.7K | SEC |
| 2024-02-12 | 02-14 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | S 公開市場賣出 | 1.8K | 5.54 | 10K | 36.1K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| FMR LLC | 19.5M | 111M | +8.9M (+84%) | 加碼 |
| BlackRock, Inc. | 13.5M | 77.3M | +2.6M (+24%) | 加碼 |
| Redmile Group, LLC | 11.9M | 67.8M | −2.7M (-18%) | 減碼 |
| STATE STREET CORP | 9.8M | 56.1M | +2.9M (+42%) | 加碼 |
| BVF INC/IL | 8.7M | 49.7M | 不變 | 持平 |
| Woodline Partners LP | 6.9M | 39.5M | +4.6M (+196%) | 加碼 |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.9M | 39.2M | +914K (+15%) | 加碼 |
| MAK CAPITAL ONE LLC | 5.9M | 33.5M | +1.1M (+24%) | 加碼 |
| GOLDMAN SACHS GROUP INC | 5.8M | 33.3M | +3.7M (+171%) | 加碼 |
| Siren, L.L.C. | 4.5M | 25.5M | +500K (+13%) | 加碼 |
| Bain Capital Life Sciences Investors, LLC | 4.4M | 25.3M | −775K (-15%) | 減碼 |
| Bellevue Group AG | 4.1M | 23.4M | −1.1M (-21%) | 減碼 |
| GEODE CAPITAL MANAGEMENT, LLC | 4.0M | 23.1M | +659K (+20%) | 加碼 |
| MPM BIOIMPACT LLC | 3.5M | 20.2M | 新進 | 新進 |
| AMERIPRISE FINANCIAL INC | 3.5M | 20.0M | +60.5K (+2%) | 加碼 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3.5M | 20.0M | −800K (-19%) | 減碼 |
| GREAT POINT PARTNERS LLC | 3.5M | 20.0M | +1.0M (+40%) | 加碼 |
| MORGAN STANLEY | 3.1M | 18.0M | +408K (+15%) | 加碼 |
| Palo Alto Investors LP | 2.9M | 16.8M | 不變 | 持平 |
| Balyasny Asset Management L.P. | 2.8M | 16.2M | −1.1M (-27%) | 減碼 |
| Nuveen, LLC | 2.8M | 15.8M | −1.5M (-35%) | 減碼 |
| Qube Research & Technologies Ltd | 2.7M | 15.7M | −364K (-12%) | 減碼 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.2M | 12.8M | +764K (+51%) | 加碼 |
| Opaleye Management Inc. | 1.7M | 9.8M | −617K (-26%) | 減碼 |
| Logos Global Management LP | 1.5M | 8.6M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 216 -1 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 31 / 32 / 77 / 74 |
| 機構合計持股 · 佔流通股 | 178M · 100.0% |
| 合計季末市值 | 1.0B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 32.1M |
|---|---|
| 與上期比 | -1.5% |
| 佔流通股數 | –(外國發行人不算) |
| 日均成交量 | 2.5M |
| 回補天數 | 12.7 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 32.1M | -1.5% | – | 2.5M | 12.7 |
| 2026-08-14 | 32.6M | +5.9% | – | 2.5M | 13.2 |
| 2026-07-31 | 30.8M | +3.2% | – | 2.9M | 10.5 |
| 2026-07-15 | 29.8M | +0.8% | – | 5.2M | 5.7 |
| 2026-06-30 | 29.6M | +12.2% | – | 5.5M | 5.4 |
| 2026-06-15 | 26.4M | +2.1% | – | 2.8M | 9.3 |
| 2026-05-29 | 25.8M | +6.4% | – | 2.7M | 9.7 |
| 2026-05-15 | 24.3M | +3.6% | – | 1.8M | 13.3 |
| 2026-04-30 | 23.4M | +19.1% | – | 2.1M | 10.9 |
| 2026-04-15 | 19.7M | +5.6% | – | 2.5M | 7.9 |
| 2026-03-31 | 18.6M | +13.6% | – | 3.3M | 5.7 |
| 2026-03-13 | 16.4M | +3.1% | – | 2.7M | 6.1 |
| 2026-02-27 | 15.9M | -1.4% | – | 2.3M | 7.0 |
| 2026-02-13 | 16.1M | -6.3% | – | 2.1M | 7.8 |
| 2026-01-30 | 17.2M | -6.6% | – | 2.2M | 7.7 |
| 2026-01-15 | 18.4M | +13.2% | – | 3.0M | 6.1 |
| 2025-12-31 | 16.3M | +33.4% | – | 2.7M | 6.0 |
| 2025-12-15 | 12.2M | +16.2% | – | 2.8M | 4.3 |
| 2025-11-28 | 10.5M | +20.3% | – | 4.5M | 2.4 |
| 2025-11-14 | 8.7M | -4.6% | – | 1.9M | 4.5 |
| 2025-10-31 | 9.2M | -10.2% | – | 2.1M | 4.4 |
| 2025-10-15 | 10.2M | +0.1% | – | 1.6M | 6.3 |
| 2025-09-30 | 10.2M | +6.4% | – | 2.6M | 3.9 |
| 2025-09-15 | 9.6M | -5.6% | – | 2.0M | 4.7 |
| 2025-08-29 | 10.1M | +2.7% | – | 1.3M | 7.7 |
| 2025-08-15 | 9.9M | +2.7% | – | 1.1M | 9.2 |